October 02, 2022
2 min watch
Source/Disclosures
Published by:
Packer M. Safety and effectiveness of a new FDA-approved dispersive ophthalmic viscosurgical device. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Disclosures:
Packer reports consulting for Bausch + Lomb and other members of the ophthalmic industrial community.
CHICAGO — In this Healio Video Perspective from the AAO meeting, Mark Packer, MD, discusses the effectiveness of ClearVisc, a new dispersive ophthalmic viscosurgical device from Bausch + Lomb.
“Here we have a new tool in our armamentarium for cataract surgery, a brand-new ophthalmic dispersive viscoelastic, which we can use to help protect the cornea and give our patients better vision on postop day 1,” he said.
American Academy of Ophthalmology Meeting
https://www.healio.com/news/ophthalmology/20221002/video-new-dispersive-viscoelastic-an-option-for-cataract-surgery